Elutia ELUT
NASDAQ ELUT
$0.92 +0.00 (+0.51%)
As of: Aug 21, 2026 · 12:43 PM EDT

Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)

Elutia (ELUT) posted Total Non-Current Liabilities of $29.3 million for Q1 2026, down 7.17% sequentially from $31.6 million in Q4 2025, and down 58.75% YoY from $71.0 million in Q1 2025.

Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Elutia has reported Total Non-Current Liabilities for 8 years, with the latest figure at $29.3 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 58.75% year-over-year to $29.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.3 million (down 58.75% YoY) and the FY2025 annual result came in at $31.6 million, down 52.42% from the prior year.
  • Total Non-Current Liabilities declined to $29.3 million in Q1 2026 per ELUT's latest filing, from $31.6 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $104.7 million in Q2 2024 and troughed at $29.3 million in Q1 2026.
  • A 5-year average of $66.7 million and a median of $71.0 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2026: Total Non-Current Liabilities surged 101.78% in 2022, then sank 58.75% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $73.7 million in 2022, then slipped by 6.07% to $69.3 million in 2023, then fell by 4.27% to $66.3 million in 2024, then sank by 52.42% to $31.6 million in 2025, then dropped by 7.17% to $29.3 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $29.3 million, $31.6 million, and $69.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 202.69 Bn 197.09 Bn 7.27 Bn -
2 Stryker 126.34 Bn 122.87 Bn 4.50 Bn 21.28 Bn
3 Medtronic 119.44 Bn 110.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.10 Bn 73.56 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.73 Bn 47.48 Bn 1.35 Bn 2.57 Bn
6 Dexcom 35.11 Bn 33.16 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.78 Bn 31.67 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.20 Bn 22.88 Bn 4.55 Bn 9.07 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 3.44 Bn
10 Elutia 40.75 Mn 20.85 Mn 1.45 Mn 24.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.29 Mn
Dec 31, 2025 31.55 Mn
Sep 30, 2025 69.30 Mn
Jun 30, 2025 66.73 Mn
Mar 31, 2025 71.02 Mn
Dec 31, 2024 66.31 Mn
Sep 30, 2024 82.40 Mn
Jun 30, 2024 104.67 Mn
Mar 31, 2024 78.00 Mn
Dec 31, 2023 69.27 Mn
Sep 30, 2023 83.62 Mn
Jun 30, 2023 74.11 Mn
Mar 31, 2023 72.60 Mn
Dec 31, 2022 73.75 Mn
Sep 30, 2022 71.62 Mn
Jun 30, 2022 53.32 Mn
Mar 31, 2022 36.85 Mn
Dec 31, 2021 52.95 Mn
Sep 30, 2021 35.49 Mn
Jun 30, 2021 38.15 Mn